Donated Livers Can Be Made Biologically Younger: How Machine Perfusion Technology Rejuvenates Organs

The "Race Against Time" in Organ Transplantation

The moment an organ is removed from a donor's body, the countdown begins. The traditional approach has surgeons flush the organ with preservation solution, seal it in a sterile bag, and place it on ice — but cold storage doesn't truly stop organ deterioration, it only slows the process. Once removed from the body, an organ begins to degrade continuously, leaving medical teams just a matter of hours to deliver it to a recipient for transplantation.

This "race against time" is one of the most challenging practical constraints in organ transplantation today. The longer the cold ischemia time, the greater the risk of impaired organ function and the more limited its usability — organs from distant donors often cannot be used due to excessive transport time, further aggravating an already severe organ shortage.

Machine Perfusion: From "Life Support" to "Repair"

Beyond traditional cold storage, a technique known as machine perfusion has been advancing rapidly in recent years. Unlike passive cold preservation, machine perfusion uses an external device to continuously pump oxygenated nutrient solution through the organ, simulating the blood flow environment inside the body and keeping the isolated organ in an active metabolic state.

The significance of this technology goes far beyond extending preservation time. Research teams have found that with carefully designed perfusion protocols, donated livers can become biologically "younger" — meaning certain aging biomarkers and functional indicators in the organ can be reversed or improved. This suggests that machine perfusion is not only a preservation method, but could also become an active platform for organ "repair" and even "restoration."

The Biological Logic Behind "Rejuvenation"

An organ's biological age does not perfectly correspond to how long it has been outside the body. Aging at the cellular level manifests as a series of measurable molecular changes, including the accumulation of metabolic byproducts, oxidative stress damage, and alterations in cellular functional markers. In an ex vivo state, if an appropriate environment of oxygen, nutrients, and temperature can be maintained — and these aging pathways can be targeted — it is theoretically possible to restore an organ's functional state to a more "youthful" level.

For an organ like the liver, which has relatively strong regenerative capacity, this possibility is especially noteworthy. The liver already possesses powerful self-repair capabilities within the body, and machine perfusion provides an operational window for activating this repair potential outside the body. Restoring a liver that is in marginal condition — and might otherwise be discarded — to a transplantable standard would directly expand the pool of available organs.

Far-Reaching Implications for Transplant Medicine

If organ "rejuvenation" technology matures and reaches clinical application, its potential impact is multifaceted.

First, expanding the organ supply. Currently, a large number of potentially viable organs are discarded due to substandard quality or excessive ischemia time. If machine perfusion can repair these marginal organs, it could effectively alleviate the global donor shortage.

Second, improving transplant success rates. An organ in better functional condition means lower risk of post-operative complications and longer graft survival time, which is critical to the recipient's long-term prognosis.

Third, providing greater flexibility in organ transport and allocation. When preservation time and organ quality are no longer absolute constraints, cross-regional and even cross-border organ sharing networks become more feasible.

A Cautious Outlook

It must be emphasized that "making organs younger" remains a frontier area of exploration, and large-scale clinical application is still some way off. The long-term safety of the relevant technologies, standardization of perfusion protocols, and cost-effectiveness all require further research and validation. Whether biological "rejuvenation" markers can reliably translate into clinical benefits for recipients also awaits more comprehensive follow-up data.

Nevertheless, this research direction represents a paradigm shift in organ transplantation — from "passive preservation" to "active repair." When organs are no longer merely perishable resources waiting to be used, but objects that can be evaluated, repaired, and even improved, the entire imaginative scope of transplant medicine will be redefined.